• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《傻瓜式健康经济诊断决策树模型:图解入门》

Health Economic Decision Tree Models of Diagnostics for Dummies: A Pictorial Primer.

作者信息

Rautenberg Tamlyn, Gerritsen Annette, Downes Martin

机构信息

Centre for Applied Health Economics, Griffith University, Nathan 4111, Australia.

EpiResult, Consultancy, Pietermaritzburg 3201, South Africa.

出版信息

Diagnostics (Basel). 2020 Mar 14;10(3):158. doi: 10.3390/diagnostics10030158.

DOI:10.3390/diagnostics10030158
PMID:32183372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7151142/
Abstract

Health economics is a discipline of economics applied to health care. One method used in health economics is decision tree modelling, which extrapolates the cost and effectiveness of competing interventions over time. Such decision tree models are the basis of reimbursement decisions in countries using health technology assessment for decision making. In many instances, these competing interventions are diagnostic technologies. Despite a wealth of excellent resources describing the decision analysis of diagnostics, two critical errors persist: not including diagnostic test accuracy in the structure of decision trees and treating sequential diagnostics as independent. These errors have consequences for the accuracy of model results, and thereby impact on decision making. This paper sets out to overcome these errors using color to link fundamental epidemiological calculations to decision tree models in a visually and intuitively appealing pictorial format. The paper is a must-read for modelers developing decision trees in the area of diagnostics for the first time and decision makers reviewing diagnostic reimbursement models.

摘要

卫生经济学是一门应用于医疗保健领域的经济学学科。卫生经济学中使用的一种方法是决策树建模,它可以推断出随着时间推移相互竞争的干预措施的成本和效果。这种决策树模型是在使用卫生技术评估进行决策的国家中报销决策的基础。在许多情况下,这些相互竞争的干预措施是诊断技术。尽管有大量优秀资源描述诊断的决策分析,但仍存在两个关键错误:在决策树结构中未纳入诊断测试准确性,以及将序贯诊断视为独立的。这些错误会影响模型结果的准确性,进而影响决策。本文旨在通过以视觉上和直观上吸引人的图形格式使用颜色将基本的流行病学计算与决策树模型联系起来,以克服这些错误。对于首次在诊断领域开发决策树的建模人员以及审查诊断报销模型的决策者来说,本文是必读之作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43dc/7151142/4ac272c8d699/diagnostics-10-00158-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43dc/7151142/5844e8a1929a/diagnostics-10-00158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43dc/7151142/35ce6786ba85/diagnostics-10-00158-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43dc/7151142/c0e14974dc1f/diagnostics-10-00158-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43dc/7151142/cfbac7d37be1/diagnostics-10-00158-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43dc/7151142/4ac272c8d699/diagnostics-10-00158-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43dc/7151142/5844e8a1929a/diagnostics-10-00158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43dc/7151142/35ce6786ba85/diagnostics-10-00158-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43dc/7151142/c0e14974dc1f/diagnostics-10-00158-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43dc/7151142/cfbac7d37be1/diagnostics-10-00158-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43dc/7151142/4ac272c8d699/diagnostics-10-00158-g005.jpg

相似文献

1
Health Economic Decision Tree Models of Diagnostics for Dummies: A Pictorial Primer.《傻瓜式健康经济诊断决策树模型:图解入门》
Diagnostics (Basel). 2020 Mar 14;10(3):158. doi: 10.3390/diagnostics10030158.
2
[Decision analytic modeling and their impact on health care decision making].[决策分析模型及其对医疗保健决策的影响]
Acta Pharm Hung. 2009;79(2):63-9.
3
Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.胎盘生长因子(单独或与可溶性fms样酪氨酸激酶1联合使用)用于辅助评估疑似子痫前期的女性:系统评价与经济分析
Health Technol Assess. 2016 Nov;20(87):1-160. doi: 10.3310/hta20870.
4
Economic evaluation and mental health: sparse past. fertile future?经济评估与心理健康:过往寥寥,未来可期?
J Ment Health Policy Econ. 1999 Dec 1;2(4):163-167. doi: 10.1002/(sici)1099-176x(199912)2:4<163::aid-mhp64>3.0.co;2-1.
5
Introduction to health economics and decision-making: Is economics relevant for the frontline clinician?健康经济学与决策导论:经济学对于一线临床医生而言是否重要?
Best Pract Res Clin Gastroenterol. 2013 Dec;27(6):831-44. doi: 10.1016/j.bpg.2013.08.016. Epub 2013 Sep 26.
6
Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.避免和识别健康技术评估模型中的错误:定性研究和方法学综述。
Health Technol Assess. 2010 May;14(25):iii-iv, ix-xii, 1-107. doi: 10.3310/hta14250.
7
The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model.用于可视化耐药性癫痫患者手术候选者致痫灶的技术的临床有效性和成本效益:系统评价和决策分析模型。
Health Technol Assess. 2012;16(34):1-157, iii-iv. doi: 10.3310/hta16340.
8
Health Economic Data in Reimbursement of New Medical Technologies: Importance of the Socio-Economic Burden as a Decision-Making Criterion.新型医疗技术报销中的卫生经济数据:社会经济负担作为决策标准的重要性
Front Pharmacol. 2016 Aug 17;7:252. doi: 10.3389/fphar.2016.00252. eCollection 2016.
9
The role of economic evidence in Canadian oncology reimbursement decision-making: to lambda and beyond.经济证据在加拿大肿瘤学报销决策中的作用:从拉姆达到更远。
Value Health. 2008 Jul-Aug;11(4):771-83. doi: 10.1111/j.1524-4733.2007.00298.x. Epub 2007 Dec 18.
10
Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.预算影响分析——良好实践原则:ISPOR 2012 预算影响分析良好实践 II 工作组报告。
Value Health. 2014 Jan-Feb;17(1):5-14. doi: 10.1016/j.jval.2013.08.2291. Epub 2013 Dec 13.

引用本文的文献

1
Echocardiography derived-left atrial stiffness index as a more cost-effective and powerful approach compared to brain natriuretic peptide for predicting left atrioventricular uncoupling in patients with acute ischemic stroke.与脑钠肽相比,超声心动图衍生的左心房僵硬度指数是预测急性缺血性脑卒中患者左房室失耦联的一种更具成本效益且强大的方法。
Quant Imaging Med Surg. 2025 Jun 6;15(6):5384-5395. doi: 10.21037/qims-24-1243. Epub 2025 May 23.
2
Health economic evaluations of diagnostic tests for tuberculosis: a narrative review.结核病诊断检测的卫生经济学评估:叙述性综述
Health Econ Rev. 2025 May 24;15(1):43. doi: 10.1186/s13561-025-00639-2.
3

本文引用的文献

1
Quantifying how diagnostic test accuracy depends on threshold in a meta-analysis.对荟萃分析中诊断测试准确性如何随阈值变化进行量化。
Stat Med. 2019 Oct 30;38(24):4789-4803. doi: 10.1002/sim.8301. Epub 2019 Sep 30.
2
Early Economic Evaluation of Diagnostic Technologies: Experiences of the NIHR Diagnostic Evidence Co-operatives.早期诊断技术的经济评价:NIHR 诊断证据合作组织的经验。
Med Decis Making. 2019 Oct;39(7):857-866. doi: 10.1177/0272989X19866415. Epub 2019 Sep 26.
3
Use of Decision Modelling in Economic Evaluations of Diagnostic Tests: An Appraisal and Review of Health Technology Assessments in the UK.
Mathematical modelling to estimate the impact of maternal and perinatal healthcare services and interventions on health in sub-Saharan Africa: A scoping review.
评估撒哈拉以南非洲地区孕产妇和围产期保健服务及干预措施对健康影响的数学模型构建:一项范围综述
PLoS One. 2024 Dec 2;19(12):e0296540. doi: 10.1371/journal.pone.0296540. eCollection 2024.
4
Self-care with non-prescription medicines to improve health care access and quality of life in low- and middle-income countries: systematic review and methodological approach.自我护理与非处方药物在改善中低收入国家的医疗可及性和生活质量方面的作用:系统评价和方法学方法。
Front Public Health. 2023 Sep 13;11:1220984. doi: 10.3389/fpubh.2023.1220984. eCollection 2023.
5
Cost-effectiveness analysis of diagnostic strategies for COVID-19 in Iran.伊朗 COVID-19 诊断策略的成本效益分析。
BMC Health Serv Res. 2023 Aug 14;23(1):861. doi: 10.1186/s12913-023-09868-9.
6
Cost analysis and economic evaluation of a virtual pediatric emergency department pilot program.虚拟儿科急诊试点项目的成本分析和经济评估。
CJEM. 2023 Sep;25(9):742-751. doi: 10.1007/s43678-023-00553-8. Epub 2023 Jul 26.
7
Cost-effectiveness of Alzheimer's disease CSF biomarkers and amyloid-PET in early-onset cognitive impairment diagnosis.阿尔茨海默病脑脊液生物标志物和淀粉样蛋白PET在早发性认知障碍诊断中的成本效益
Eur Arch Psychiatry Clin Neurosci. 2023 Feb;273(1):243-252. doi: 10.1007/s00406-022-01439-z. Epub 2022 Jun 16.
8
Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer-A Cost-Efficient Strategy in a Public Healthcare System.ROS1 免疫组化(IHC)检测伴 FISH 验证用于晚期非小细胞肺癌——公共医疗体系下一种具有成本效益的策略
Curr Oncol. 2021 Aug 25;28(5):3268-3279. doi: 10.3390/curroncol28050284.
9
Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review.呼吸道感染诊断的经济学分析:系统评价。
Pharmacoeconomics. 2021 Dec;39(12):1411-1427. doi: 10.1007/s40273-021-01054-1. Epub 2021 Jul 15.
决策建模在诊断测试经济评估中的应用:对英国卫生技术评估的评估与综述
Pharmacoecon Open. 2019 Sep;3(3):281-291. doi: 10.1007/s41669-018-0109-9.
4
PD-L1 immunostaining scoring for non-small cell lung cancer based on immunosurveillance parameters.基于免疫监视参数的非小细胞肺癌 PD-L1 免疫组化评分。
PLoS One. 2018 Jun 6;13(6):e0196464. doi: 10.1371/journal.pone.0196464. eCollection 2018.
5
An economic model to value companion diagnostics in non-small-cell lung cancer.一种用于评估非小细胞肺癌伴随诊断价值的经济模型。
Per Med. 2013 Mar;10(2):139-147. doi: 10.2217/pme.13.7.
6
Establishing the Value of Diagnostic and Prognostic Tests in Health Technology Assessment.建立诊断和预后测试在卫生技术评估中的价值。
Med Decis Making. 2018 May;38(4):495-508. doi: 10.1177/0272989X17749829. Epub 2018 Mar 13.
7
Sensitivity, Specificity, and Predictive Values: Foundations, Pliabilities, and Pitfalls in Research and Practice.敏感性、特异性和预测值:研究与实践中的基础、灵活性及陷阱
Front Public Health. 2017 Nov 20;5:307. doi: 10.3389/fpubh.2017.00307. eCollection 2017.
8
Measures of Diagnostic Accuracy: Basic Definitions.诊断准确性的测量:基本定义。
EJIFCC. 2009 Jan 20;19(4):203-11. eCollection 2009 Jan.
9
Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist.在靶向肿瘤治疗的经济评估中对伴随诊断进行建模:系统评价与方法学清单
Expert Rev Mol Diagn. 2015 Feb;15(2):235-54. doi: 10.1586/14737159.2014.929499. Epub 2014 Aug 21.
10
Methods for identifying the cost-effective case definition cut-off for sequential monitoring tests: an extension of Phelps and Mushlin.确定序贯监测测试中具有成本效益的病例定义临界值的方法:费尔普斯和穆斯林方法的扩展
Pharmacoeconomics. 2014 Apr;32(4):327-34. doi: 10.1007/s40273-014-0134-1.